An official in the Chinese Centre for Disease Control and Prevention, Guizhen Wu, has predicted that the COVID-19 vaccines being developed in China may be ready for use by the general public as early as November 2020.
France24.com reported this prediction. According to the press release, China has four COVID-19 vaccines in the final stage of clinical trials. At least three of those drugs have already been offered to essential workers under an emergency use programme which began in July.
In an interview with state TV on Monday, Wu said the phase three clinical trials were proceeding smoothly, and the vaccines could be ready for the general public in November or December.
[READ ALSO] Arik Air Resumes Flight Operations
Wu noted that she had not experienced any abnormal symptoms in recent months after taking an experimental vaccine herself in April. However, she did not specify which vaccines she was referring to.
A unit of state pharmaceutical giant, China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech are currently developing the three COVID-19 vaccines under the state’s emergency use programme. A fourth Covid-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.
Sinopharm in July said that its vaccine could be ready for public use by the end of 2020 after the conclusion of phase three trials.